A partial agonist that binds with high affinity to the alpha4beta2 subtype of the nicotinic acetylcholine receptor.
This receptor subtype has been implicated in nicotine dependence and is the primary target of varenicline. I
It is more effective than placebo for smoking cessation (West R et al.